PFM Health Sciences LP Has $33.79 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

PFM Health Sciences LP boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 4.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 124,840 shares of the company’s stock after purchasing an additional 5,305 shares during the quarter. HCA Healthcare accounts for approximately 2.0% of PFM Health Sciences LP’s holdings, making the stock its 17th biggest position. PFM Health Sciences LP’s holdings in HCA Healthcare were worth $33,792,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Stone House Investment Management LLC bought a new position in HCA Healthcare during the third quarter valued at about $25,000. Centerpoint Advisors LLC bought a new position in HCA Healthcare in the fourth quarter worth $27,000. Atlantic Edge Private Wealth Management LLC bought a new stake in HCA Healthcare in the 4th quarter valued at $27,000. Bruce G. Allen Investments LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth about $28,000. Finally, FinTrust Capital Advisors LLC increased its stake in HCA Healthcare by 26.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after acquiring an additional 35 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the transaction, the senior vice president now directly owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,617 shares of company stock worth $4,321,986. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Up 0.0 %

Shares of NYSE HCA traded up $0.10 during mid-day trading on Thursday, hitting $340.91. The company’s stock had a trading volume of 654,212 shares, compared to its average volume of 1,071,843. The company’s fifty day simple moving average is $320.39 and its 200-day simple moving average is $312.43. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $343.53. The stock has a market cap of $89.29 billion, a price-to-earnings ratio of 16.99, a price-to-earnings-growth ratio of 1.58 and a beta of 1.69. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.93 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft upped their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Royal Bank of Canada lifted their price objective on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Cantor Fitzgerald reiterated an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a research report on Wednesday, April 10th. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 8th. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $325.59.

Get Our Latest Stock Analysis on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.